← Leaderboards
Anna Sf Lok
University Of Michigan At Ann Arbor
$10,814,527
Attributed
$14,681,568
Total exposure
15
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$14,681,568 · 15
By mechanism
U01$11,063,158 · 4
R44$1,994,570 · 1
M01$730,114 · 8
T32$660,947 · 1
N01$232,779 · 1
Top collaborators
- Grace L. Su5 shared
- Thomas D Wang5 shared
- Peter D.R. Higgins4 shared
- Steven-Huy B Han2 shared
- Xiaohui Ni2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Kathy F Harrington$2,778,098
- Melissa A. Valerio-Shewmaker$216,017
- James R Baker$11,149,531
- Debbie Wan Hua Chen$547,368
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical TrialsLiver DiseasesPrimary Carcinoma Of The Liver CellsEnrollmentResponseHepatitis BIncidenceUniversitiesMichiganHepatitis CInfectionCombined Modality TherapySiteEpidemiologyHepatitis B VirusHepatitis B E AntigensCirrhosisSafetyHawaiiAcute HepatitisCollaborationsHepatitis B TherapyImmunology
Grant awards (48)
MethylScan for Early Detection of Liver and Lung Cancer$997,285
R44 · FY2023 · CA
MethylScan for Early Detection of Liver and Lung Cancer$997,285
R44 · FY2022 · CA
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION$665,380
U01 · FY2022 · CA · contact PI
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION$530,030
U01 · FY2021 · CA · contact PI
Training Program in Gastrointestinal Epidemiology$168,302
T32 · FY2021 · DK · contact PI
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION$791,318
U01 · FY2020 · CA · contact PI
Training Program in Gastrointestinal Epidemiology$164,261
T32 · FY2020 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan - Hawaii Consortium$47,162
U01 · FY2020 · DK · contact PI
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION$658,591
U01 · FY2019 · CA · contact PI
Training Program in Gastrointestinal Epidemiology$157,860
T32 · FY2019 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan - Hawaii Consortium$148,640
U01 · FY2019 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan - Hawaii Consortium$47,136
U01 · FY2019 · DK · contact PI
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION$664,962
U01 · FY2018 · CA · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan - Hawaii Consortium$241,832
U01 · FY2018 · DK · contact PI
Training Program in Gastrointestinal Epidemiology$170,524
T32 · FY2018 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan - Hawaii Consortium$35,145
U01 · FY2018 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan - Hawaii Consortium$276,228
U01 · FY2017 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan - Hawaii Consortium$239,044
U01 · FY2016 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan - Hawaii Consortium$216,547
U01 · FY2016 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan - Hawaii Consortium$344,498
U01 · FY2015 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan-Hawaii consortium$61,386
U01 · FY2015 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan-Hawaii consortium$47,665
U01 · FY2015 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan-Hawaii consortium$141,396
U01 · FY2014 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan-Hawaii consortium$373,319
U01 · FY2013 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan-Hawaii consortium$309,148
U01 · FY2012 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan-Hawaii consortium$235,477
U01 · FY2011 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan-Hawaii consortium$362,578
U01 · FY2010 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan-Hawaii consortium$401,256
U01 · FY2009 · DK · contact PI
Hepatitis B Clinical Research Network Clinical Center: Michigan-Hawaii consortium$143,168
U01 · FY2008 · DK · contact PI
RECURRENT HEPATITIS B AFTER LIVER TRANSPLANTATION$349,339
U01 · FY2007 · DK · contact PI
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C) TRIAL$46,545
M01 · FY2007 · RR · contact PI
INACTIVE CARRIERS OF HEP B VIRUS & HEPB E ANTIGEN-NEG CHRONIC HEPB IN NAMER$12,880
M01 · FY2007 · RR · contact PI
RECURRENT HEPATITIS B AFTER LIVER TRANSPLANTATION$373,442
U01 · FY2006 · DK · contact PI
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C) TRIAL$155,334
M01 · FY2006 · RR · contact PI
INACTIVE CARRIERS OF HEP B VIRUS & HEPB E ANTIGEN-NEG CHRONIC HEPB IN NAMER$38,833
M01 · FY2006 · RR · contact PI
HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT TO PREVENT CIRRHOSIS (HALT-C) TRIAL$197,623
M01 · FY2005 · RR
VIRAHEP-C Clinical Center$115,000
U01 · FY2005 · DK
INACTIVE CARRIERS OF HEP B VIRUS &HEPB E ANTIGEN-NEG CHRONIC HEPB IN NAMER$11,837
M01 · FY2005 · RR
RECURRENT HEPATITIS B AFTER LIVER TRANSPLANTATION$953,315
U01 · FY2004 · DK
Hepatitis C Antiviral Long-term Treatment to Prevent Cirrhosis (HALT-C) Trial$266,348
M01 · FY2004 · RR
Factors Associated with Advanced Fibrosis in Patients with Chronic Hepatitis C$508
M01 · FY2004 · RR
RECURRENT HEPATITIS B AFTER LIVER TRANSPLANTATION$897,263
U01 · FY2003 · DK
RECURRENT HEPATITIS B AFTER LIVER TRANSPLANTATION$772,609
U01 · FY2002 · DK
Impact of hepatitis C on health related quality of life$0
M01 · FY2002 · RR
RECURRENT HEPATITIS B AFTER LIVER TRANSPLANTATION$620,284
U01 · FY2001 · DK
HEPATITIS C CLINICAL TRIAL-CLINICAL CENTERS$232,779
N01 · FY2000 · DK
SAFETY &EFFECT OF VPA 985 IN TREATMENT OF PATIENTS W/ HYPONATREMIA$206
M01 · FY2000 · RR
Impact of hepatitis C on health related quality of life$0
M01 · FY2000 · RR